Full Name
Kam Man Hui
Variants
HUI, KAM MAN
Hui, K.M.
HUI, KAM M.
Hui, K.
 
 
 
Email
gmshkm@nus.edu.sg
 
 

Refined By:
Date Issued:  [2000 TO 2023]
Type:  Article
File Format:  Adobe PDF

Results 1-15 of 15 (Search time: 0.019 seconds).

Issue DateTitleAuthor(s)
12017A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinomaDai X.; Wang L. ; Deivasigamni A.; Looi C.Y.; Karthikeyan C.; Trivedi P.; Chinnathambi A.; Alharbi S.A.; Arfuso F.; Dharmarajan A.; Goh B.C. ; Hui K.M. ; Kumar A.P. ; Mustafa M.R.; Sethi G. 
22017An anti-human lutheran glycoprotein phage antibody inhibits cell migration on laminin-511: Epitope mapping of the antibodyEnomoto-Okawa Y.; Maeda Y.; Harashima N.; Sugawara Y.; Katagiri F.; Hozumi K.; Hui K.M. ; Nomizu M.; Ito Y.; Kikkawa Y.
32017An improved pre-clinical patient-derived liquid xenograft mouse model for acute myeloid leukemiaHer Z.; Yong K.S.M.; Paramasivam K.; Tan W.W.S.; Chan X.Y.; Tan S.Y.; Liu M. ; Fan Y.; Linn Y.C. ; Hui K.M. ; Surana U. ; Chen Q. 
42020Brusatol suppresses STAT3-driven metastasis by downregulating epithelial-mesenchymal transition in hepatocellular carcinomaLee, J.H.; Mohan, C.D.; Deivasigamani, A.; Jung, Y.Y.; Rangappa, S.; Basappa, S.; Chinnathambi, A.; Alahmadi, T.A.; Alharbi, S.A.; Garg, M.; Lin, Z.-X.; Rangappa, K.S.; Sethi, G. ; Hui, K.M. ; Ahn, K.S.
52017Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancerXia H.; Hui K.M. 
627-Sep-2021Epigenetic derepression converts PPAR gamma into a druggable target in triple-negative and endocrine-resistant breast cancersLoo, Ser Yue; Syn, Nicholas L; Koh, Angele Pei-Fern ; Teng, Janet Cheng-Fei ; Deivasigamani, Amudha; Tan, Tuan Zea ; Thike, Aye Aye ; Vali, Shireen ; Kapoor, Shweta; Wang, Xiaoyuan ; Wang, Jiong Wei ; Tan, Puay Hoon ; Yip, George W ; Sethi, Gautam ; Huang, Ruby Yun-Ju ; Hui, Kam Man ; Wang, Lingzhi ; Goh, Boon Cher ; Kumar, Alan Prem 
72015Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkersLi F. ; Shanmugam M.K. ; Siveen K.S. ; Wang F. ; Ong T.H.; Loo S.Y. ; Swamy M.M.M.; Mandal S.; Kumar A.P. ; Goh B.C. ; Kundu T.; Ahn K.S.; Wang L.Z. ; Hui K.M. ; Sethi G. 
82017Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiformeNewman J.P.; Wang G.Y.; Arima K.; Guan S.P. ; Waters M.R.; Cavenee W.K.; Pan E.; Aliwarga E. ; Chong S.T.; Kok C.Y.L.; Endaya B.B.; Habib A.A.; Horibe T.; Ng W.H. ; Ho I.A.W. ; Hui K.M. ; Kordula T.; Lam P.Y.P. 
94-Sep-2012MiR-214 Targets β-Catenin Pathway to Suppress Invasion, Stem-Like Traits and Recurrence of Human Hepatocellular CarcinomaXia, H.; Ooi, L.L.P.J.; Hui, K.M. 
102019PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoproteinThura M.; Al-Aidaroos A.Q.; Gupta A. ; Chee C.E. ; Lee S.C. ; Hui K.M. ; Li J.; Guan Y.K. ; Yong W.P. ; So J. ; Chng W.J. ; Ng C.H. ; Zhou J. ; Wang L.Z. ; Yuen J.S.P. ; Ho H.S.S. ; Yi S.M.; Chiong E. ; Choo S.P. ; Ngeow J. ; Ng M.C.H. ; Chua C. ; Yeo E.S.A. ; Tan I.B.H. ; Sng J.X.E.; Tan N.Y.Z.; Thiery J.P. ; Goh B.C. ; Zeng Q. 
112-Nov-2021PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein (vol 10, 2484, 2019)Thura, Min; Al-Aidaroos, Abdul Qader; Gupta, Abhishek ; Chee, Cheng Ean ; Lee, Soo Chin ; Hui, Kam Man ; Li, Jie; Guan, Yeoh Khay ; Yong, Wei Peng ; So, Jimmy; Chng, Wee Joo ; Ng, Chin Hin ; Zhou, Jianbiao ; Wang, Ling Zhi; Yuen, John Shyi Peng; Ho, Henry Sun Sien ; Yi, Sim Mei; Chiong, Edmund ; Choo, Su Pin ; Ngeow, Joanne; Ng, Matthew Chau Hsien ; Chua, Clarinda; Yeo, Eugene Shen Ann ; Tan, Iain Bee Huat ; Sng, Joel Xuan En; Tan, Nicholas Yan Zhi; Thiery, Jean Paul ; Goh, Boon Cher ; Zeng, Qi 
122019Relevance of a TCGA-derived Glioblastoma Subtype Gene-Classifier among Patient PopulationsTeo, W.-Y.; Sekar, K.; Seshachalam, P.; Shen, J.; Chow, W.-Y.; Lau, C.C.; Yang, H.K.; Park, J.; Kang, S.-G.; Li, X.; Nam, D.-H.; Hui, K.M. 
132015The over-expression of survivin enhances the chemotherapeutic efficacy of YM155 in human hepatocellular carcinomaXia H.; Chen J.; Shi M.; Deivasigamani A.; Ooi L.L.P.J. ; Hui K.M. 
142014?-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse modelSiveen K.S. ; Ahn K.S.; Ong T.H.; Shanmugam M.K. ; Li F. ; Yap W.N.; Kumar A.P. ; Fong C.W.; Tergaonkar V. ; Hui K.M. ; Sethi G. 
1531-Oct-2021Tris(Dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathwayArora, Loukik; Mohan, Chakrabhavi Dhananjaya; Yang, Min Hee; Rangappa, Shobith; Deivasigamani, Amudha; Kumar, Alan Prem ; Kunnumakkara, Ajaikumar B.; Garg, Manoj; Chinnathambi, Arunachalam; Alharbi, Sulaiman Ali; Alahmadi, Tahani Awad; Rangappa, Kanchugarakoppal S.; Hui, Kam Man ; Sethi, Gautam ; Ahn, Kwang Seok